Published in J Clin Microbiol on April 01, 2005
Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol (2007) 1.18
Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan. J Clin Microbiol (2006) 1.11
Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect Dis (2006) 0.94
Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China. BMC Infect Dis (2013) 0.88
Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. Epidemiol Infect (2006) 0.83
Incidence and anatomic localization of oral candidiasis in patients with AIDS hospitalized in a public hospital in Belo Horizonte, MG, Brazil. J Appl Oral Sci (2008) 0.83
Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. J Negat Results Biomed (2008) 0.83
Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole. PLoS One (2012) 0.82
Oropharyngeal colonization of HIV-infected outpatients in Taiwan by yeast pathogens. J Clin Microbiol (2010) 0.78
Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India. J Pathog (2016) 0.75
Diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to CD4(+) counts. Indian J Sex Transm Dis (2015) 0.75
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis (2003) 4.29
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2001) 4.05
Molecular mechanisms of drug resistance in fungi. Trends Microbiol (1994) 3.55
Mycoses caused by Candida lusitaniae. Rev Infect Dis (1988) 2.53
The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS (1991) 1.81
Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol (1992) 1.65
Mechanism of fluconazole resistance in Candida krusei. Antimicrob Agents Chemother (1998) 1.52
Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization. J Infect Dis (1999) 1.51
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Molecular typing of candida albicans isolated from oral lesions of HIV-infected individuals. AIDS (1992) 1.20
Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis (2002) 1.19
Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers. J Clin Microbiol (1995) 1.15
Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin Infect Dis (2000) 1.12
Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.04
Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS (2003) 1.03
Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect (2003) 1.03
Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation (1996) 1.02
Changing prevalence of human immunodeficiency virus-associated oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 0.92
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis (2005) 4.52
Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis (2008) 3.95
Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis (2007) 3.21
Current status of Clostridium difficile infection epidemiology. Clin Infect Dis (2012) 3.14
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis (2006) 2.98
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med (2013) 2.78
Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J Bacteriol (2009) 2.64
Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis (2008) 2.61
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis (2006) 2.43
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis (2012) 2.34
ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis (2006) 2.27
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis (2009) 2.24
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob Agents Chemother (2007) 2.01
Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol (2009) 2.00
Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis (2008) 1.98
Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med (2006) 1.91
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet (2010) 1.90
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One (2013) 1.84
Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob Agents Chemother (2006) 1.76
National estimates of central line-associated bloodstream infections in critical care patients. Infect Control Hosp Epidemiol (2013) 1.69
Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis (2008) 1.67
The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis (2007) 1.66
Vancomycin-resistant staphylococci and enterococci: epidemiology and control. Curr Opin Infect Dis (2005) 1.56
A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis (2005) 1.56
Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg Infect Dis (2009) 1.55
Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis (2010) 1.53
Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med (2007) 1.50
Wrestling SARS from uncertainty. Emerg Infect Dis (2004) 1.50
Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol (2008) 1.45
Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis (2004) 1.45
Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan. Arch Intern Med (2005) 1.42
Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol (2009) 1.38
Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer (2005) 1.38
A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med (2011) 1.38
Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control (2007) 1.35
A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med (2006) 1.34
Copy Number Change of the NDM-1 sequence in a multidrug-resistant Klebsiella pneumoniae clinical isolate. PLoS One (2013) 1.33
Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrob Agents Chemother (2002) 1.31
The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis (2008) 1.31
Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS (2003) 1.29
Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol (2010) 1.29
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae. Antimicrob Agents Chemother (2007) 1.28
The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int J Antimicrob Agents (2004) 1.28
Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol (2003) 1.26
Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis (2011) 1.26
Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol (2008) 1.25
CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob Agents Chemother (2004) 1.24
Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol (2009) 1.23
Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet Gynecol (2007) 1.23
Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol (2009) 1.23
Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol (2004) 1.22
Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin Cancer Res (2007) 1.22
A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clin Infect Dis (2007) 1.20
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis (2010) 1.20
Complete sequences of two plasmids in a blaNDM-1-positive Klebsiella oxytoca isolate from Taiwan. Antimicrob Agents Chemother (2013) 1.19
Mobilization of qnrB2 and ISCR1 in plasmids. Antimicrob Agents Chemother (2008) 1.19
Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med (2005) 1.18
Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol (2008) 1.18
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis (2004) 1.18
Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol (2007) 1.18
Increased risk for Entamoeba histolytica infection and invasive amebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Negl Trop Dis (2008) 1.16
Methicillin-resistant Staphylococcus aureus in Taiwan. Emerg Infect Dis (2005) 1.14
Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis (2007) 1.12
Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan. Am J Trop Med Hyg (2006) 1.11
A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.11
Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan. J Clin Microbiol (2006) 1.11
Clostridium difficile: responding to a new threat from an old enemy. Infect Control Hosp Epidemiol (2005) 1.10
Hormone replacement therapy and lung cancer risk in Chinese. Cancer (2007) 1.09
Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis (2005) 1.09
The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). J Biomed Sci (2007) 1.09
Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS One (2007) 1.09
Bench-to-bedside review: Clostridium difficile colitis. Crit Care (2008) 1.08
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol (2007) 1.08
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 1.07
Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis (2004) 1.07
Clostridium difficile infections in children. Pediatr Infect Dis J (2009) 1.07
Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant (2007) 1.06
Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect (2003) 1.05
Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol (2011) 1.05
Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. Cancer Res (2004) 1.04
Lack of SARS transmission among healthcare workers, United States. Emerg Infect Dis (2004) 1.04
Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One (2013) 1.04
Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS (2003) 1.03
Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect (2003) 1.03
Clostridium difficile strains from community-associated infections. J Clin Microbiol (2009) 1.03
Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis (2013) 1.03